Posted in | News | Control Systems

Hollysys to Provide DCS for Ultra-Supercritical Coal Fire Power Generating Units to Guohua Shouguang Power Plant

Hollysys Automation Technologies, Ltd., a leading provider of automation and control technologies and applications in China, announced today that it has won the contract to provide its proprietary Distributed Control System for 2×1000MW ultra-supercritical coal fire power generating units to Guohua Shouguang Power Plant. The units are expected to be operated in June 2016 and in November 2016 respectively.

The 2×1000MW ultra-supercritical coal fire power generating units of Guohua Shouguang Power Plant is a key project in Shandong Province, which is funded and constructed by Shenhua Guohua Power. The total DCS control points are over 40,000, which is the largest scale adopting one brand DCS in doing the automation and control for 1000MW power generating units today.

Hollysys won this project from the fierce competition with globally well-known automation companies and local company. And Hollysys was finally awarded this contract because of its leading and well recognized technology, solution, product and service. This is another significant contract win to strengthen Hollysys' high-end power industry position.

Hollysys' management commented: "We are very excited of the contract win to apply our proprietary DCS to the largest scale of power generating units in China, which evidenced our leading technology and capability again. We will continue to organize our industry professional teams to further penetrate the high-end segments of the industrial automation market and intensify our sales efforts in the low to mid-end market to further enhance our overall market position, and create value for our shareholders."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.